ReShape Lifesciences Inc. (RSLS)
USD 0.49
(29.26%)
USD 0.49
(29.26%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 151 Thousand USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 163 Thousand USD | -65.83% |
| 2019 | 477 Thousand USD | 0.0% |
| 2018 | - USD | -100.0% |
| 2017 | 7.96 Million USD | -19.4% |
| 2016 | 9.88 Million USD | 1697.23% |
| 2015 | 549.79 Thousand USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 6.86 Million USD | -29.08% |
| 2012 | 9.68 Million USD | 236.11% |
| 2011 | 2.88 Million USD | -42.18% |
| 2010 | 4.98 Million USD | -35.79% |
| 2009 | 7.76 Million USD | -29.42% |
| 2008 | 10.99 Million USD | 82.72% |
| 2007 | 6.01 Million USD | 248.46% |
| 2006 | 1.72 Million USD | -76.49% |
| 2005 | 7.34 Million USD | 0.0% |
| 2003 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 127 Thousand USD | 0.0% |
| 2024 Q2 | 103 Thousand USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 FY | 151 Thousand USD | 0.0% |
| 2023 Q4 | 151 Thousand USD | -13.71% |
| 2023 Q3 | 175 Thousand USD | -11.62% |
| 2023 Q2 | 198 Thousand USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 Q2 | - USD | -100.0% |
| 2022 Q1 | 86 Thousand USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 Q1 | 82 Thousand USD | -49.69% |
| 2021 FY | - USD | -100.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q2 | - USD | -100.0% |
| 2021 Q4 | - USD | 0.0% |
| 2020 Q2 | 323 Thousand USD | -19.65% |
| 2020 FY | 163 Thousand USD | -65.83% |
| 2020 Q1 | 402 Thousand USD | -15.72% |
| 2020 Q4 | 163 Thousand USD | -32.92% |
| 2020 Q3 | 243 Thousand USD | -24.77% |
| 2019 Q3 | 552 Thousand USD | -11.82% |
| 2019 FY | 477 Thousand USD | 0.0% |
| 2019 Q4 | 477 Thousand USD | -13.59% |
| 2019 Q1 | 700 Thousand USD | 0.0% |
| 2019 Q2 | 626 Thousand USD | -10.57% |
| 2018 Q3 | 9.39 Million USD | 57.17% |
| 2018 Q1 | 6.97 Million USD | -12.44% |
| 2018 FY | - USD | -100.0% |
| 2018 Q4 | - USD | -100.0% |
| 2018 Q2 | 5.98 Million USD | -14.24% |
| 2017 Q1 | 9.89 Million USD | 0.1% |
| 2017 FY | 7.96 Million USD | -19.4% |
| 2017 Q4 | 7.96 Million USD | -11.07% |
| 2017 Q3 | 8.95 Million USD | -9.55% |
| 2017 Q2 | 9.9 Million USD | 0.1% |
| 2016 Q3 | 1.23 Million USD | -84.2% |
| 2016 Q4 | 9.88 Million USD | 698.87% |
| 2016 FY | 9.88 Million USD | 1697.23% |
| 2016 Q2 | 7.83 Million USD | 53.05% |
| 2016 Q1 | 5.11 Million USD | 830.58% |
| 2015 Q4 | 549.79 Thousand USD | 0.0% |
| 2015 FY | 549.79 Thousand USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | - USD | -100.0% |
| 2014 Q3 | - USD | -100.0% |
| 2014 Q2 | 932.12 Thousand USD | -84.21% |
| 2014 Q1 | 5.9 Million USD | -14.05% |
| 2013 Q2 | 4.78 Million USD | -50.86% |
| 2013 Q1 | 9.73 Million USD | 0.53% |
| 2013 Q4 | 6.86 Million USD | -12.26% |
| 2013 FY | 6.86 Million USD | -29.08% |
| 2013 Q3 | 7.82 Million USD | 63.64% |
| 2012 Q2 | 8.58 Million USD | 91.69% |
| 2012 Q4 | 9.68 Million USD | 26.86% |
| 2012 FY | 9.68 Million USD | 236.11% |
| 2012 Q1 | 4.47 Million USD | 55.43% |
| 2012 Q3 | 7.63 Million USD | -11.08% |
| 2011 Q4 | 2.88 Million USD | -15.88% |
| 2011 Q2 | 3.95 Million USD | -11.71% |
| 2011 Q3 | 3.42 Million USD | -13.44% |
| 2011 FY | 2.88 Million USD | -42.18% |
| 2011 Q1 | 4.48 Million USD | -10.06% |
| 2010 Q2 | 4.92 Million USD | 68.48% |
| 2010 Q4 | 4.98 Million USD | 21.12% |
| 2010 Q1 | 2.92 Million USD | -24.73% |
| 2010 FY | 4.98 Million USD | -35.79% |
| 2010 Q3 | 4.11 Million USD | -16.4% |
| 2009 FY | 7.76 Million USD | -29.42% |
| 2009 Q2 | 18.51 Million USD | 89.77% |
| 2009 Q4 | 3.88 Million USD | -77.17% |
| 2009 Q3 | 16.99 Million USD | -8.16% |
| 2009 Q1 | 9.75 Million USD | -11.29% |
| 2008 Q2 | 4.26 Million USD | -17.33% |
| 2008 Q4 | 10.99 Million USD | 228.68% |
| 2008 Q3 | 3.34 Million USD | -21.48% |
| 2008 FY | 10.99 Million USD | 82.72% |
| 2008 Q1 | 5.15 Million USD | -14.36% |
| 2007 FY | 6.01 Million USD | 248.46% |
| 2007 Q4 | 6.01 Million USD | 17.31% |
| 2007 Q3 | 5.12 Million USD | 0.0% |
| 2006 Q4 | 1.72 Million USD | 0.0% |
| 2006 FY | 1.72 Million USD | -76.49% |
| 2005 FY | 7.34 Million USD | 0.0% |
| 2005 Q4 | 7.34 Million USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 99.582% |
| BrainsWay Ltd. | 239 Thousand USD | 36.82% |
| Cerus Corporation | 59.79 Million USD | 99.747% |
| Envoy Medical, Inc. | 404 Thousand USD | 62.624% |
| electroCore, Inc. | 537 Thousand USD | 71.881% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -1158.333% |
| IceCure Medical Ltd | 376 Thousand USD | 59.84% |
| Inogen, Inc. | 18.27 Million USD | 99.174% |
| OrthoPediatrics Corp. | 13.45 Million USD | 98.878% |
| Lucid Diagnostics Inc. | 199 Thousand USD | 24.121% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | 58.485% |
| MaxCyte, Inc. | 17.96 Million USD | 99.16% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -173.135% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 99.838% |
| PAVmed Inc | 2.96 Million USD | 94.899% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 97.57% |
| RxSight, Inc. | 1.21 Million USD | 87.531% |
| Sight Sciences, Inc. | 31.7 Million USD | 99.524% |
| SI-BONE, Inc. | 36.06 Million USD | 99.581% |
| TELA Bio, Inc. | 40.51 Million USD | 99.627% |
| Treace Medical Concepts, Inc. | 53 Million USD | 99.715% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | 90.072% |
| Acutus Medical, Inc. | 32.65 Million USD | 99.538% |
| Talis Biomedical Corporation | 16.78 Million USD | 99.1% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | 96.267% |
| CVRx, Inc. | 30.38 Million USD | 99.503% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | 85.151% |
| Bioventus Inc. | 366.99 Million USD | 99.959% |
| Venus Concept Inc. | 70.79 Million USD | 99.787% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | 87.862% |
| LivaNova PLC | 568.54 Million USD | 99.973% |
| 908 Devices Inc. | 3.92 Million USD | 96.157% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 99.97% |
| Nemaura Medical Inc. | 3.08 Million USD | 95.11% |
| NeuroPace, Inc. | 56.95 Million USD | 99.735% |
| LENSAR, Inc. | 1.75 Million USD | 91.371% |
| Apyx Medical Corporation | 33.18 Million USD | 99.545% |
| Cutera, Inc. | 418.69 Million USD | 99.964% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 98.996% |
| BioSig Technologies, Inc. | 103 Thousand USD | -46.602% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 99.439% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 98.482% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.99% |
| Axonics, Inc. | 25.84 Million USD | 99.416% |
| Outset Medical, Inc. | 134.59 Million USD | 99.888% |
| IRIDEX Corporation | 1.75 Million USD | 91.376% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 99.706% |
| IRadimed Corporation | 1.61 Million USD | 90.651% |
| Tivic Health Systems, Inc. | 176 Thousand USD | 14.205% |
| INVO Bioscience, Inc. | 6.77 Million USD | 97.772% |
| Telesis Bio, Inc. | 5.26 Million USD | 97.134% |
| Viemed Healthcare, Inc. | 5.97 Million USD | 97.471% |
| Varex Imaging Corporation | 464.2 Million USD | 99.967% |
| Quipt Home Medical Corp. | 60.82 Million USD | 99.752% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 74.32% |
| Pulmonx Corporation | 35.08 Million USD | 99.57% |
| Dynatronics Corporation | 3.25 Million USD | 95.366% |
| Modular Medical, Inc. | 817 Thousand USD | 81.518% |
| Semler Scientific, Inc. | 70 Thousand USD | -115.714% |
| InMode Ltd. | 6.61 Million USD | 97.717% |
| Bruker Corporation | 1.14 Billion USD | 99.987% |
| Cytosorbents Corporation | 2.54 Million USD | 94.062% |
| DexCom, Inc. | 2.57 Billion USD | 99.994% |
| Align Technology, Inc. | 96.96 Million USD | 99.844% |
| Viveve Medical, Inc. | 5.12 Million USD | 97.053% |
| ZimVie Inc. | 508.79 Million USD | 99.97% |
| Movano Inc. | 15.00 USD | -1006566.667% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 99.167% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.962% |
| Profound Medical Corp. | 4.97 Million USD | 96.964% |
| Insulet Corporation | 1.36 Billion USD | 99.989% |
| enVVeno Medical Corporation | 1.06 Million USD | 85.808% |
| Surmodics, Inc. | 29.4 Million USD | 99.486% |
| iCAD, Inc. | 273 Thousand USD | 44.689% |
| Nuwellis, Inc. | 221 Thousand USD | 31.674% |
| Biotricity, Inc. | 10.85 Million USD | 98.609% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 99.568% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | 76.76% |
| InspireMD, Inc. | 1.03 Million USD | 85.453% |
| PAVmed Inc. | 2.96 Million USD | 94.899% |
| BIOLASE, Inc. | 13.98 Million USD | 98.92% |
| Beyond Air, Inc. | 14.72 Million USD | 98.974% |
| FONAR Corporation | 37.92 Million USD | 99.602% |
| AxoGen, Inc. | 46.6 Million USD | 99.676% |
| Vivani Medical, Inc. | 19.31 Million USD | 99.218% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 99.662% |
| Inari Medical, Inc. | 30.35 Million USD | 99.503% |
| UFP Technologies, Inc. | 28 Million USD | 99.461% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | 65.211% |
| Tenon Medical, Inc. | 428 Thousand USD | 64.72% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 84.93% |
| Co-Diagnostics, Inc. | 2.15 Million USD | 92.984% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.993% |
| Sintx Technologies, Inc. | 3.68 Million USD | 95.905% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 99.594% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 74.32% |
| Sensus Healthcare, Inc. | 596 Thousand USD | 74.664% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.983% |
| TransMedics Group, Inc. | 506.2 Million USD | 99.97% |
| ReWalk Robotics Ltd. | 607 Thousand USD | 75.124% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -63.27% |
| Hyperfine, Inc. | 64 Thousand USD | -135.938% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 99.92% |
| Biomerica, Inc. | 459 Thousand USD | 67.102% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 66.406% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | 20.521% |
| Silk Road Medical, Inc | 75.62 Million USD | 99.8% |